Molecular pathogenesis of non-Hodgkin's lymphoma
Taniwaki, M.; Matsumoto, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 119-125
2012
ISSN/ISBN: 0047-1852 PMID: 23133939 Document Number: 663901
Document emailed within 1 workday
Related Documents
Mitarnun, W.; Pradutkanchana, J.; Takao, S.; Saechan, V.; Suwiwat, S.; Ishida, T. 2002: Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis Journal of the Medical Association of Thailand 85(5): 552-559Louie, S.; Daoust, P.R.; Schwartz, R.S. 1980: Immunodeficiency and the pathogenesis of non-Hodgkin's lymphoma Seminars in Oncology 7(3): 267-284
Gaidano, G.; Gloghini, A.; Pastore, C.; Carbone, A. 1995: Recent insights on the pathogenesis of non-Hodgkin's lymphoma Pathologica 87(6): 595-602
Yazici, H.; Saip, P.; Inanç, S.; Onat, H.; Dalay, N. 1998: Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma Research Communications in Molecular Pathology and Pharmacology 100(3): 301-311
Goncharova, O.V.; Bermisheva, M.A.; Giliazova, I.R.; Lipatov, O.N.; Khusnutdinova, E.K. 2009: Molecular-genetic approach to study of non-Hodgkin's lymphoma Voprosy Onkologii 55(2): 151-157
Ong, S.T.; Le Beau, M.M. 1998: Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma Seminars in Oncology 25(4): 447-460
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Hebert, J.; Romana, S.P.; Hillion, J.; Kerkaert, J.P.; Bastard, C.; Berger, R. 1993: Translocation t(3;22)(q27;q11) in non-Hodgkin's malignant lymphoma: chromosome painting and molecular studies Leukemia 7(12): 1971-1974
Svejgaard, A.; Madsen, H.O.; Nyvold, C.; Ryder, L.P.; Schmiegelow, K. 1996: Molecular biology diagnosis and monitoring in acute lymphoblastic leukemia and non-Hodgkin-lymphoma Ugeskrift for Laeger 158(49): 7101-7102
Van Krieken, J.H.; McKeithan, T.W.; Raghoebier, S.; Medeiros, L.J.; Kluin, P.M.; Raffeld, M. 1990: Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases Leukemia 4(12): 811-812
Trimeche, M.; Korbi, S.; Ziadi, S.; Amara, K.; Boniver, J.; de Leval, L. 2005: Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: prevalence of the LMP1 oncogene deletions and a and B viruses strains Annales de Biologie Clinique 63(2): 193-199
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Avalos, B.R.; Klein, J.L.; Kapoor, N.; Tutschka, P.J.; Klein, J.P.; Copelan, E.A. 1993: Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY Bone Marrow Transplantation 12(2): 133-138
Schouten, H.C. 1992: Chromosome aberrations in non-Hodgkin lymphoma and in Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 136(19): 913-917
Fernández-Llamazares, J.; de la Cruz, J.; Bianchi, A.; Ribera, J.M. 1999: Primary non-Hodgkin's lymphoma of the esophagus following Hodgkin's disease Medicina Clinica 112(9): 356-357